Promising research trials surrounding the medication Retatrutide , specifically the high-dose formulation ZPHC ZPHC, suggest a significant benefit on weight decrease and associated metabolic conditions . Scientists posit that this innovative acting , targeting both GLP-1 and GIP pathways , has the potential to represent a substantial breakthrough